The Society for Women’s Health Research (SWHR) is pleased to welcome three new members to its Board of Directors this January 2022: Jim Carey, Judette Louis, MD, MPH, and Erika Miller, JD. SWHR and its Board members are committed to continuing the advancement of research on biological sex differences in disease and improvement of women’s health through science, policy, and education.
“We are delighted to welcome three strong health care leaders to the board this year. I know they will each play an important role in helping SWHR shape the future of women’s health research, and I look forward to the work we can continue to accomplish together,” said Shontelle Dodson, PharmD, SWHR Board Chair.
Carey is the head of U.S. Policy and Government Affairs for Organon and Co., a global health care company formed through a spinoff from Merck in June 2021, with vision of ‘a better and healthier every day for every woman’. He leads federal and state policy and government relations. Carey has more than three decades of experience in pharmaceutical industry federal and state public policy. “I’m very excited for the opportunity to join such a vital and well-respected organization as SWHR. During its three decades of focus on gaps in women’s health research, SWHR has made a palpable difference. But there’s more work to be done and I’m proud to be a part of that,” said Carey.
Dr. Louis is the chair of the Department of OB/GYN at the University of South Florida and has a joint faculty appointment in both the College of Public Health and the College of Medicine. She conducts research on obstructive sleep apnea in pregnant women, and she is an advocate of inclusion of pregnant women in clinical trials. “Now more than ever, we need to influence change so that all, including pregnant women, can benefit from research and clinical trials,” Dr. Louis said. She also previously served as a member of SWHR’s Interdisciplinary Network on Sleep.
Miller serves as senior vice president and counsel at CRD Associates, LLC in Washington, D.C. Through her career, she has developed broad experience in government relations representing a range of non-profit organizations—from medical specialty societies and coalitions to patient advocacy organizations. She previously worked in the office of Congressman Steve Rothman of New Jersey and the U.S. Department of Health and Human Services Office on Women’s Health.
“SWHR is lucky to have such a distinguished group of new Board members, and I personally am delighted to be working with Dr. Louis, Mr. Carey and Ms. Miller,” said Kathryn G. Schubert, MPP, CAE, President & CEO at SWHR. “I have worked with each of them in other capacities in the past, and each brings a unique perspective and dedication to the advancement of women’s health research and SWHR.”
SWHR thanks all current and former Board members for their work helping make women’s health mainstream, with extra appreciation to Dr. Nieca Goldberg and Dr. David Page for their Board service through 2021. Goldberg is a cardiologist, medical director of NYU Langone Medical Center’s Joan H. Tisch Center for Women’s Health, and clinical associate professor of medicine at the NYU School of Medicine, among other roles. Page serves as the director of the Whitehead Institute, a professor of biology at the Massachusetts Institute of Technology, and an investigator of the Howard Hughes Medical Institute.
A full list of the SWHR Board of Directors is available here.